论文部分内容阅读
Zeneca公司的抗偏头痛药zdmitriptan（商品名Zomig）在另外3个欧盟成员国：丹麦。德国和芬兰获得许可。瑞典是10个欧洲国家许可的参照国。本品在所有欧洲国家的许可估计要持续到1997年下半年及整个1998年。Zolmitriptan获其它欧盟国家许可
Zeneca’s anti-migraine drug zdmitriptan (trade name Zomig) is in three other EU member states: Denmark. Germany and Finland are licensed. Sweden is a reference country licensed by 10 European countries. This product in all European countries is estimated to continue until the second half of 1997 and throughout 1998. Zolmitriptan is licensed by other EU countries